Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 24, 2017 3:26 PM 2 min read

Spruce Point Stands By Short-Sale Thesis Against PTC, Urges Stakeholders To Exercise Caution

by Lizzy Balboa Benzinga Staff Writer
Follow
PTC Logo
PTCPTC Inc
$156.13-%
Overview

After a day of back-and-forth between Spruce Point Capital and PTC Inc (NASDAQ:PTC), Spruce Point reiterated its short-sell position to Benzinga and stood by its negative assessment of PTC.

“Our in-depth forensic research leads to the inescapable conclusion that investors have over-valued the company and overlooked such factors as its poorly executed subscription model transition, aggressive use of unsupportable non-GAAP financial measures, and over-hyped but underperforming Internet of Things business,” a firm representative said.

The activist investment manager had accused the company Thursday of violating SEC disclosure requirements and GAAP financial reporting guidelines.

Alleged Voilations Outlined

Short Thesis, Explained

In a short thesis predicting 50 to 60 percent downside, Spruce Capital evaluated “weak financial results in favor of dubious metrics,” which are unrelated to future revenues.

“PTC’s five-year recurring restructuring odyssey appears to be an elaborate accounting scheme to sell investors on meaningless non-GAAP figures,” Spruce Capital wrote. “We’ve done a deep dive analysis and are shocked by PTC’s overstatement of office locations, and irreconcilable employee headcounts. Are they just firing and re-hiring people to expunge expenses?”

PTC responded Friday afternoon by justifying its use of GAAP measures and subscription performance metrics as common practices among software companies.

“The company believes it is existing the subscription transition trough and that its results will begin to reflect the expected benefits of our strategic execution and business model transition, including accelerated revenue growth, margin expansion, and earnings growth, that we expect will translate into even greater returns for PTC shareholders,” PTC wrote in a statement.

Following PTC’s response, Spruce Point tweeted a note of caution to stakeholders.

Related Links:

'Whole Lot Of Competition' Makes Whole Foods A Sell At UBS

Don't Feed The Bears

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
NewsShort SellersShort IdeasMoversTrading IdeasSpruce Point CapitalSprucepoint Capital
PTC Logo
PTCPTC Inc
$156.13-%
Overview
Comments
Loading...